Endograft Technology: Highlights of the Past 10 Years
|
|
- Shannon Casey
- 6 years ago
- Views:
Transcription
1 II-192 J ENDOVASC THER REVIEW Endograft Technology: Highlights of the Past 10 Years Thomas J. Fogarty, MD; Frank R. Arko, MD; and Christopher K. Zarins, MD Division of Vascular Surgery, Stanford University Medical Center, Stanford, California, USA. The past decade has seen the evolution of an exciting technology that has changed forever the treatment of aortic aneurysmal disease. From rather crude homemade stent-grafts constructed in the surgical suite to elegant commercially manufactured devices in a variety of configurations and sizes, the aortic endograft has experienced a meteoric rise in popularity to become a beneficial, minimally invasive therapy that can obviate the risk of rupture and death. There are now 3 approved endovascular devices on the market for infrarenal abdominal aortic aneurysm repair, and it is likely that additional and improved devices will become available in the future. This review revisits the developmental history of the aortic endograft, noting the ongoing refinements that have arisen from our experiences with the growing population of stent-graft patients. Although research continues to search for solutions to the problems of endoleak and migration, long-term results even with the earlier second and third-generation devices are better than has been achieved with open surgical repair. J Endovasc Ther Key words: abdominal aortic aneurysm, stent-graft, device design, stent, graft material, endoleak, rupture The treatment of aortic aneurysms has changed dramatically over the past 10 years as a result of innovative endovascular strategies and the development and application of new technology. Juan Parodi s 1 demonstration that blood flow could be excluded from an abdominal aortic aneurysm (AAA) using a transluminally placed surgical graft aroused worldwide interest in the potential of endovascular aneurysm repair. The benefits to the patient of a minimally invasive transfemoral approach that did not require aortic crossclamping were obvious. However, the technological challenges of designing a suitable endoluminal device that could exclude the aneurysm from the circulation and withstand the formidable biomechanical forces of pulsatile aortic blood flow were felt by some to be insurmountable compared to the security of sutured surgical grafts. Some viewed the new experimental endovascular approach as doomed to failure, considering the longstanding experience with open surgery and the comfort level that vascular surgeons had with the procedure. Nonetheless, the past decade has witnessed remarkably rapid technological advances in endovascular device design and delivery systems as a result of collaborations among vascular surgeons, engineers, interventional radiologists, and industry. A number of devices have been evaluated in multicenter controlled clinical trials, and all have shown that endovascular repair is effective in preventing aneurysm rupture with less periprocedural morbidity, faster patient recovery, Address for correspondence and reprints: Christopher K. Zarins, MD, Division of Vascular Surgery, 300 Pasteur Drive, Room H-3642, Stanford University Medical Center, Stanford, CA USA. Fax: ; zarins@stanford.edu 2004 by the INTERNATIONAL SOCIETY OF ENDOVASCULAR SPECIALISTS Available at
2 J ENDOVASC THER II-193 and earlier return to function than open surgical repair. In 1999, only 8 years after Parodi s first successful endovascular AAA procedure, the Food and Drug Administration (FDA) granted market approval for two endovascular devices, the AneuRx 2 (Medtronic Vascular, Santa Rosa, CA, USA) and the Ancure 3 (Guidant Corporation, Indianapolis, IN, USA). Although the Ancure endograft is no longer on the market, the AneuRx device has gained wide clinical acceptance, with more than 50,000 patients treated worldwide. Favorable long-term clinical results now extend to more than 8 years. 4 More recently, two additional devices have gained FDA approval, the Excluder 5 (W.L. Gore & Associates, Flagstaff, AZ, USA) and the Zenith 6 (Cook Inc., Bloomington, IN, USA). Thus, in the short span of 10 years, stentgraft repair has revolutionized the treatment of aneurysms and become the procedure of choice for suitable patients with infrarenal AAA. While endovascular repair of thoracic aortic aneurysms (TAA) has been performed for more than 10 years with good clinical success, 7 technological challenges have delayed FDA approval and widespread clinical application in the US. It is anticipated that endovascular devices for thoracic and thoracoabdominal aneurysms will become available in the near future. DEVELOPMENT OF ENDOVASCULAR DEVICES The principle of endovascular repair is similar to open surgical repair, in which exclusion of the aneurysm from the aortic bloodstream is achieved by attaching a prosthetic graft to the nonaneurysmal aorta proximally and distally. Early endovascular devices were constructed by suturing polyester prosthetic grafts to selfexpanding or balloon-expandable stents that served to anchor the graft to the nonaneurysmal aorta by applying radial force to the aortic neck. These early homemade devices were designed to treat selected AAAs and descending TAAs, either as tube grafts or as aortomonoiliac exclusions with contralateral iliac occlusion and femorofemoral bypass. These first-generation devices had large delivery systems and significant limitations. The need for better endograft designs with smaller diameter delivery systems and the ability to deal with the complex anatomy of aortoiliac aneurysms quickly became apparent. Early design considerations included bifurcated unibody grafts versus modular systems, differing graft materials and weave densities, self-expanding versus balloon-expandable stents, exoskeleton versus endoskeleton, radial force versus hook fixation, columnar support versus flexibility, suprarenal versus infrarenal fixation, delivery system diameter, flexibility and design, and percutaneous versus open delivery. A variety of endovascular devices were developed by multiple manufacturers utilizing different strategies of construction, fixation, and deployment. The early Endovascular Technologies (EVT) aortic tube graft, first deployed by Wesley Moore in 1994, 8 had limited usefulness since most aortic aneurysms involved the aortic bifurcation. 9 This device was replaced by a unibody bifurcated endograft design that required a complex delivery system to deploy the contralateral iliac limb. Simpler delivery systems were possible using a modular component design and bifemoral device deployment. In addition, the EVT graft had no radial support in the iliac limbs and thus was prone to extrinsic graft compression or kinking in diseased and tortuous iliac arteries. Stent and hook fractures, as well as fabric density and durability, were important issues in early devices. Stent-graft construction options included placing the stent inside (endoskeleton) or outside (exoskeleton) of the fabric graft, and a variety of attachment mechanisms were used to join the stent to the fabric. In areas of severe angulation, an endoskeletal configuration could result in abrasion of the polyester fabric against the ends of the metallic stents, with perforation of the graft material. Such fabric tears could lead to device failure and aneurysm rupture. 10 The exoskeletal structure mitigated this problem and also increased surface friction between the stent and the aortic wall, allowing tissue in-growth into the interstices of the stent to assist in anchoring the device. Suprarenal fixation mechanisms, with and without hooks, were successfully incor-
3 II-194 J ENDOVASC THER Figure 1Evolution and improvement of the AneuRx stent-graft. (A) The early prototype stiff bifurcation module (left) was replaced with a segmented stent structure (right) that added flexibility to the device. (B) Fabric weave density was increased (C) in order to reduce porosity and enhance durability. (D) The blunt-nosed delivery system that was used during the clinical trial was replaced with an improved tapered tip delivery system (E) in porated into some devices to improve fixation in angulated aortic necks. 6,11 A discussion of the design variables in stent-graft construction and the search for the ideal endograft design were summarized by Robert Allen several years ago. 12 Using these concepts, a modular stent-graft design with a simple, intuitive delivery system was designed by Fogarty Engineering more than 10 years ago. This modular endograft design was a new conceptual approach at that time, utilizing both radial fixation force and longitudinal columnar support to maintain position in the aorta. Mechanical and bench testing and animal implantations were begun in 1994, 13 and the first human implantation was performed in A controlled phase II multicenter clinical trial was completed in 1998, resulting in FDA approval of the AneuRx stent-graft in This stent-graft design remains one of the most widely used endografts for AAA repair worldwide, with durable long-term results. 14 Early clinical experiences and endograft device failures resulted in rapid advances and evolution in device design. For example, it was learned that the early prototype AneuRx bifurcation module was too stiff and did not conform well in angulated aortoiliac aneurysms. Thus, in 1997, the bifurcation module was modified to a segmented stent design that allowed flexibility of the device (Fig. 1A). In addition, a more tightly woven fabric with reduced porosity (Fig. 1 B,C) was introduced in 1998 in order to eliminate transgraft flow, which was commonly seen on completion angiograms. Furthermore, it was observed that retraction of the runners in the delivery system after deployment caused excessive friction between the delivery system sheath and the bifurcated endograft module, which could displace the stent-graft and necessitate implantation of aortic extender cuffs. The delivery system was subsequently improved to significantly reduce the friction in the runner system, thus preventing intraoperative device migration. This new delivery system, which was introduced in 2002, included a tapered nosecone to replace the original blunt bullet configuration (Fig. 1 D,E), which also lowered the outer diameter of the introducer sheath to 21-F. The current AneuRx stent-graft is now in its 4 th generation of device design. Improve-
4 J ENDOVASC THER II-195 ments have addressed issues of deployment, delivery, density of fabric weave, and ease of use, while maintaining the same basic qualities of the ideal endovascular device. Future changes of this device will include improved radiopaque markers, a longer main body, an increased variety of sizes, and an integrated deployment handle. Similar technological advances and improvements have occurred with other endovascular devices in the past decade. For example, the polytetrafluoroethylene (PTFE) fabric of the Excluder endoprosthesis has recently been modified to reduce its porosity in an attempt to decrease or eliminate the problem of aneurysm enlargement associated with this graft material. The Cook Zenith is also modifying its outer stent design by increasing the space between the stents in an attempt to increase the flexibility of this device. ENDOVASCULAR SKILLS AND TRAINING AND IMPROVED IMAGING Equally important to the rapid technological advances in device design was the need to provide the vascular surgical community with endovascular skills and training. Endovascular repair was a new conceptual strategy for treating aortic aneurysms quite unlike open surgical repair. While many vascular surgeons, particularly those involved with the early clinical trials, had some endovascular experience in peripheral occlusive disease, this was an entirely new approach to aneurysms for most vascular surgeons. It required an intimate knowledge of pre and postoperative imaging modalities, including cross-sectional computed tomography (CT) with 3-dimensional reconstruction. It also required the skills to work under fluoroscopy with indirect imaging, to use guidewires and catheters, and to perform angiographic imaging and interpretation. It required conceptualizing nonsurgical aneurysm exclusion strategies that were quite different from the well developed techniques of open aortic aneurysm repair. Thus, it was no surprise that early efforts were met with resistance and skepticism from some segments of the traditional vascular surgery community. When the first prospective clinical trials of endovascular aneurysm repair began in 1995 (EVT-EGS system) and 1996 (AneuRx), few vascular surgeons had the experience and endovascular skills needed to deploy endovascular devices. For most clinical sites in these multicenter trials, this was the first institutional experience with endovascular aneurysm repair. Thus, a steep learning curve existed in both the trials, which required assembling endovascular teams, imaging facilities, equipment, and support systems. Collaborations between vascular surgeons and interventional radiologists and/or cardiologists facilitated the successful deployment of the devices, which required femoral artery exposure and repair. Early imaging systems often were suboptimal. For example, we began endovascular aneurysm repair in the operating room at Stanford in 1996 using a portable 9-inch OEC 9400 C-arm fluoroscope and a table top ruler to help with positioning of the device. However, despite these early limitations, the results of endovascular aneurysm repair were remarkably good, with a 98% to 99% deployment success rate and a significant reduction in operative time and blood loss, with shorter hospital stays, fewer complications, and faster recovery compared to open surgical repair. 2,3,5,6 After a decade of experience and exposure, most vascular surgeons have acquired the skills needed to successfully treat patients with endovascular grafts. The unequivocal benefit of endovascular repair over open surgery has recently been confirmed in two European prospective randomized trials. Both the British and Dutch studies showed that endovascular aneurysm repair had a 3 to 4-fold reduction in operative mortality compared to open surgical repair. 15,16 Since completion of the first endograft clinical trials in 1999, there have been marked improvements in imaging systems, techniques, and endovascular skills, which allow greater precision in endograft deployment and positioning. Magnification images, C-arm angulation and rotation, moveable fluoroscopy tables, and effective catheters, guidewires, and sheaths are now used routinely by vascular surgeons who have acquired impressive catheters skills. The education of the vascular surgery community was facilitated by manufacturer-supported training programs in endovascular
5 II-196 J ENDOVASC THER aneurysm repair, which was a condition of FDA approval of the endovascular devices in These educational efforts have been very effective in improving the skills of vascular surgeons and have favorably impacted the outcomes using all devices. THE LEARNING CURVE: OUTCOME ANALYSIS DRIVEN In addition to the technical aspects of patient selection and device deployment, much has been learned during the past 10 years about long-term device performance. Much of the learning curve with respect to long-term outcomes has occurred as a result of ongoing clinical and image surveillance of patients who had been enrolled into the Ancure and AneuRx clinical trials. During the course of these studies, the primary endpoint of success was believed to be complete aneurysm exclusion with elimination of endoleak (flow in the aneurysm sac). It was assumed that if there was no endoleak, the risk of aneurysm rupture had been eliminated. To this day, some consider endoleak to be the primary measure of long-term success of endovascular repair. However, after the clinical trials were completed, reports of aneurysm rupture appeared, prompting much discussion and a detailed failure analysis of patients who experienced rupture. This analysis, published in May 2000, 17 showed that the 7 patients who experienced post-implant rupture among almost 1200 patients treated during the AneuRx trial all had evidence of poor stent-graft fixation proximally, distally, or at the junction gate. Furthermore, evidence for such poor fixation could be seen on the immediate postimplant CT scans and plain abdominal radiographs in all the rupture patients. Moreover, the defects were visible on follow-up imaging studies for up to 2 years before aneurysm rupture occurred, which suggested that rupture might have been prevented if poor fixation had been (1) avoided by more precise device deployment and use of extender cuffs at the initial procedure or (2) corrected by performing a secondary procedure to secure fixation with extender cuffs when imaging studies showed evidence of poor fixation (Fig. 2). This information on the importance of fixation was incorporated into all training courses and was disseminated to physicians beginning in 2000, thus reducing the risk of rupture. It is also interesting to note that the risk of rupture was higher among patients treated with the early stiff bifurcated module that was used at the beginning of the clinical trial. 18 The lack of flexibility of this prototype device increased the likelihood of poor fixation in areas of neck angulation and confirmed the importance of device fixation. Although the stiff device was used only in the very early phases of the clinical trial and has never been commercially available, these ruptures remain in the reported long-term outcomes with the AneuRx device. 14 Similar early learning curve ruptures have also been observed with the Ancure and other stent-graft devices, but they usually have not been included in long-term outcome reporting. 19 The longterm risk of rupture for patients treated with the current FDA-approved devices is very low, although occasional ruptures do still occur, and ongoing patient monitoring is needed. A surprise finding of the AneuRx rupture analysis was that 5 of the 7 rupture patients had no evidence of endoleak on repeated postprocedural CT studies prior to rupture. The 2 patients with endoleak had poor or absent fixation of the device to the iliac artery, which resulted in prominent type I endoleaks; however, both patients refused treatment. These observations raised questions regarding the significance of endoleaks and what it means if a patient has an endoleak. Is this really a useful predictive endpoint, as we had assumed during the clinical trial? In order to answer these questions, we utilized objective Core Laboratory documentation of endoleak on serial postprocedural CT scans from 383 patients in phase II of the multicenter trial. We found that the presence or absence of an endoleak was not a predictor of the endpoints of aneurysm rupture, surgical conversion, stent-graft migration, or patient survival. 20 The presence of an endoleak was related to an increased likelihood of aneurysm enlargement of 5 mm or more. However, most patients with enlargement have not required treatment, and sac expansion, with or without endoleak, was not related to an increased risk of rupture or decreased surviv-
6 J ENDOVASC THER II-197 Figure 2Successful endovascular repair yesterday (A) and today (B). (A) This patient was considered to have a successful endovascular repair since the aneurysm was completely excluded from the circulation, and there was no endoleak. However, the device is positioned far below the renal arteries and barely into the iliac arteries, thus predisposing the patient to stent-graft migration and possible rupture. (B) Current deployment techniques seek to position the device just below the renal arteries with extension of the limbs to the level of the hypogastric arteries, thus providing long-term stability. al. 21 These findings have now been confirmed by others, and type II endoleaks in and of themselves are no longer viewed as strong indicators of risk of rupture. LONG-TERM DURABILITY: STENT-GRAFT MIGRATION Long-term durability of endovascular aneurysm repair requires maintenance of endograft position and seal against the relentless downward force of pulsatile aortic blood flow. A variety of fixation mechanisms have been employed, including infrarenal fixation, suprarenal fixation, hooks, barbs, radial force, and longitudinal columnar support. Regardless of the fixation mechanism, migration has been noted with all current endovascular devices. The migration rate is 2% at 1 year using each of the FDA-approved devices. 5,22,23 In a longer term analysis of migration among AneuRx clinical trial patients, we found that the same factors that were of importance in preventing aneurysm rupture are also important in preventing stent-graft migration. During a 5-year period, migration was identified in 94 (8%) of 1119 patients. However, the migration rates varied widely among the 13 clinical sites (0% to 30%, Fig. 3), which suggests that factors other than the device played a major role in determining migration, since all sites used the same device. Indeed, multivariate analysis showed that low deployment of the device below the renal arteries was the most important predictor of subsequent migration. For each millimeter increase in the distance between the renal arteries and the top of the stent-graft on postdeployment CT scans, the risk of subsequent migration increased by 6%. 21 Thus, several sites, even some with large clinical experiences, consistently deployed the device low in the aortic neck, predisposing to migration. Further analysis revealed that iliac fixation length was also of great importance in preventing migration. Given the early phase of the learning
7 II-198 J ENDOVASC THER Figure 3Migration rates according to clinical site in the AneuRx clinical trial. The migration rate varied from 0% to 30% among the 13 clinical sites, suggesting that factors other than the device played a major role in determining migration. curve, the less refined imaging techniques, and the primary focus on endoleak as a procedural endpoint during the clinical trial, it is not surprising that the device was deployed well below the renal arteries and barely into the iliac arteries in some patients. If no endoleak was seen on completion angiography, the procedure was deemed to be a success. The fact that short initial proximal and distal fixation lengths predisposed to late stentgraft migration was appreciated only years later. Stent-graft migration is now considered to be preventable by positioning the device just below the renal arteries and extending the device to the level of the hypogastric artery bilaterally (Fig. 2B). Similar long-term analysis is needed for all endovascular devices. LONG-TERM OUTCOME AND PROSPECTS FOR THE FUTURE This past decade has witnessed a remarkable evolution and transformation in our approach to the treatment of aortic aneurysms. Even with the learning curve and early clinical trial results included, the long-term outcomes of endovascular infrarenal AAA repair are excellent. Five-year Kaplan-Meier results are now available for all 1193 patients treated during the AneuRx clinical trial from 1996 to 1999, including early prototype devices and the high-risk and off-protocol patients. 4 They show results that are considerably better than open surgical repair, with a remarkable 97% freedom from rupture and aneurysm-related death and a 91% freedom from surgical conversion at 5 years. Similar favorable longterm results using other FDA-approved devices may be expected in the future. In the next decade we can expect continuing improvements in endovascular device design to include the treatment of juxtarenal, suprarenal, and thoracoabdominal aneurysms. Clinical trials of devices to treat descending TAAs are nearing completion and should have FDA approval in the near future. The role of open surgical repair of aortic aneurysms will diminish but not disappear. As we gain experience and skill in endovascular aortic aneurysm repair, surgeons will be challenged to maintain their skills in open repair. REFERENCES 1. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg. 1991;5: Zarins CK, White RA, Schwarten D, et al.
8 J ENDOVASC THER II-199 AneuRx stent graft versus open surgical repair of abdominal aortic aneurysms: multicenter prospective clinical trial. J Vasc Surg. 1999;29: Makaroun MS, Chaikof E, Naslund T, et al. Efficacy of a bifurcated endograft versus open repair of abdominal aortic aneurysms: a reappraisal. J Vasc Surg. 2002;35: Zarins CK. The new gold standard? The AneuRx clinical trial at 8 years: lessons learned following the US AneuRx clinical trial from 1996 to Endovascular Today. 2004; July Supplement: Matsumura JS, Brewster DC, Makaroun MS, et al. A multicenter controlled clinical trial of open versus endovascular treatment of abdominal aortic aneurysm. J Vasc Surg. 2003;37: Greenberg RK, Lawrence-Brown M, Bhandari G, et al. An update of the Zenith endovascular graft for abdominal aortic aneurysms: initial implantation and mid-term follow-up data. J Vasc Surg. 2001;33:S Dake MD, Miller DC, Semba CP, et al. Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med. 1994;331: Moore WS, Vescera CL. Repair of abdominal aortic aneurysm by transfemoral endovascular graft placement. Ann Surg. 1994;220: Moore WS, Rutherford RB. Transfemoral endovascular repair of abdominal aortic aneurysm: results of the North American EVT phase 1 trial. J Vasc Surg. 1996;23: Beebe HG, Cronenwett JL, Katzen BT, et al. Results of an aortic endograft trial: impact of device failure beyond 12 months. J Vasc Surg. 2001;33:S Criado FJ, Fairman RM, Becker GJ. Talent LPS AAA stent graft: results of a pivotal clinical trial. J Vasc Surg. 2003;37: Allen RC, White RA, Zarins CK, et al. What are the characteristics of the ideal endovascular graft for abdominal aortic aneurysm exclusion? J Endovasc Surg. 1997;4: Beygui RE, Kinney EV, Pelc LR, et al. Prevention of spinal cord ischemia in an ovine model of abdominal aortic aneurysm treated with a selfexpanding stent-graft. J Endovasc Surg. 1999; 6: Zarins CK; AneuRx Clinical Investigators. The US AneuRx Clinical Trial: 6-year clinical update J Vasc Surg. 2003;37: Greenhalgh RM, Brown LC, Kwong GP, et al. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet. 2004;364: Prinssen M, Verhoeven ELG, Buth J, et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2004;351: Zarins CK, White RA, Fogarty TJ. Aneurysm rupture after endovascular repair using the AneuRx stent graft. J Vasc Surg. 2000;31: Zarins CK, White RA, Moll FL, et al. The AneuRx stent graft: four-year results and worldwide experience J Vasc Surg. 2001; 33:S Bernhard VM, Mitchell RS, Matsumura JS, et al. Ruptured abdominal aortic aneurysm after endovascular repair. J Vasc Surg. 2002;35: Zarins CK, White RA, Hodgson KJ, et al. Endoleak as a predictor of outcome after endovascular aneurysm repair: AneuRx multicenter clinical trial. J Vasc Surg. 2000;32: Zarins CK, Bloch DA, Crabtree T, et al. Aneurysm enlargement following endovascular aneurysm repair: AneuRx clinical trial. J Vasc Surg. 2004;39: Zarins CK, Bloch DA, Crabtree T, et al. Stent graft migration after endovascular aneurysm repair: importance of proximal fixation. J Vasc Surg. 2003;38: Sternbergh WC3rd, Money SR, Greenberg RK, et al. Influence of endograft oversizing on device migration, endoleak, aneurysm shrinkage, and aortic neck dilation: results from the Zenith Multicenter Trial. J Vasc Surg. 2004;39:20 26.
From 1996 to 1999, a total of 1,193 patients with
THE ANEURX CLINICAL TRIAL AT 8 YEARS Lessons learned following the US AneuRx clinical trial from 1996 to 2004. BY CHRISTOPHER K. ZARINS, MD From 1996 to 1999, a total of 1,193 patients with infrarenal
More informationIncreased Flexibility of AneuRx Stent-Graft Reduces Need for Secondary Intervention Following Endovascular Aneurysm Repair
583 Increased Flexibility of AneuRx Stent-Graft Reduces Need for Secondary Intervention Following Endovascular Aneurysm Repair Frank R. Arko, MD; W. Anthony Lee, MD; Bradley B. Hill, MD; Paul Cipriano,
More informationHistory of the Powerlink System Design and Clinical Results. Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ
History of the Powerlink System Design and Clinical Results Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ Powerlink System: Unibody-Bifurcated Design Long Main Body Low-Porosity Proprietary eptfe
More informationTalent Abdominal Stent Graft
Talent Abdominal with THE Xcelerant Hydro Delivery System Expanding the Indications for EVAR Treat More Patients Short Necks The Talent Abdominal is the only FDA-approved device for proximal aortic neck
More informationEccentric stent graft compression: An indicator of insecure proximal fixation of aortic stent graft
Eccentric stent graft compression: An indicator of insecure proximal fixation of aortic stent graft Yehuda G. Wolf, MD, Bradley B. Hill, MD, W. Anthony Lee, MD, Christine M. Corcoran, RN, MS, Thomas J.
More informationIliac fixation inhibits migration of both suprarenal and infrarenal aortic endografts
From the Society for Vascular Surgery Iliac fixation inhibits migration of both suprarenal and infrarenal aortic endografts Peyman Benharash, MD, Jason T. Lee, MD, Oscar J. Abilez, MD, Tami Crabtree, MS,
More informationDurable outcomes. Proven performance.
Durable outcomes. Proven performance. GORE EXCLUDER AAA Endoprosthesis GORE EXCLUDER Iliac Branch Endoprosthesis GORE EXCLUDER AAA Endoprosthesis The most-studied* EVAR stent graft designed for durable
More informationBifurcated system Proximal suprarenal stent Modular (aortic main body and two iliac legs) Full thickness woven polyester graft material Fully
Physician Training Bifurcated system Proximal suprarenal stent Modular (aortic main body and two iliac legs) Full thickness woven polyester graft material Fully supported by self-expanding z-stents H&L-B
More informationEndovascular Repair o Abdominal. Aortic Aneurysms. Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida
Endovascular Repair o Abdominal Aortic Aneurysms Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida Disclosure Nothing to disclose. 2 Mr. X AAA Mr. X. Is a 70 year old male who presented to
More informationLOWERING THE PROFILE RAISING THE BAR
LOWERING THE PROFILE RAISING THE BAR INNOVATIVE LOW PROFILE. ADVANCED CLINICAL PERFORMANCE. The AFX TM Endovascular AAA System integrates anatomical fixation with an advanced delivery system and graft
More informationAbdominal and thoracic aneurysm repair
Abdominal and thoracic aneurysm repair William A. Gray MD Director, Endovascular Intervention Cardiovascular Research Foundation Columbia University Medical Center Abdominal Aortic Aneurysm Endografts
More informationEndologix PowerWeb System EPW?
13 579 583 2004 Endologix PowerWeb System EPW? Endologix PowerWeb System EPW (AAA) 1993 7 2003 11 AAA 176 155 21 52 897240 120mm 53.5mm EPWEPW 1 2 proximal neck PN 15mm 3 PN 23mm 4 distal neck DN 15mm
More informationZenith Renu AAA Converter Graft. Device Description Planning and Sizing Deployment Sequence Patient Follow-Up
Zenith Renu AAA Converter Graft Device Description Planning and Sizing Deployment Sequence Patient Follow-Up Device description: Device indications The Zenith Renu AAA Converter Graft with Z-Trak Introduction
More informationAortic stents, types, selection, tricks in deployment.
Aortic stents, types, selection, tricks in deployment. Hamdy Soliman.M.D,FSCAI Consultant of Cardiology&Head of Endovascular Unit National Heart Institute Endovascular Treatment of Thoracic Aortic Aneurysms
More informationPAPER. Morphologic Changes and Outcome Following Endovascular Abdominal Aortic Aneurysm Repair as a Function of Aneurysm Size
PAPER Morphologic Changes and Outcome Following Endovascular Abdominal Aortic Aneurysm Repair as a Function of Aneurysm Size Frank R. Arko, MD; Konstantinos A. Filis, MD; Bradley B. Hill, MD; Thomas J.
More informationThe US AneuRx Clinical Trial: 6-year clinical update 2002
The US AneuRx Clinical Trial: 6-year clinical update 2002 Christopher K. Zarins, MD, for the AneuRx Clinical Investigators,* Stanford, Calif A total of 1193 patients with infrarenal abdominal aortic aneurysms
More informationAccess More Patients. Customize Each Seal.
Access More. Customize Each Seal. The Least Invasive Path Towards Proven Patency ULTRA LOW PROFILE TO EASE ADVANCEMENT The flexible, ultra-low 12F ID Ovation ix delivery system enables you to navigate
More informationCurrent Status of Abdominal Aortic Stent Grafts. John R. Laird Professor of Medicine Director of the Vascular Center UC Davis Medical Center
Current Status of Abdominal Aortic Stent Grafts John R. Laird Professor of Medicine Director of the Vascular Center UC Davis Medical Center Autumn Greetings Disclosure Statement of Financial Interest Within
More informationTHE THE MORE MORE NATURAL APPROACH TO OPTIMAL FIT
THE THE MORE MORE NATURAL APPROACH Natural Approach TO Optimal Fit TO OPTIMAL FIT Conformability without Compromise THE STANDARD IN Conformability AND Designed for flexibility and conformability in tortuous
More informationCurrent Status of EVAR for Infrarenal AAA. 31 st Annual Florida Vascular Society. PENN Surgery
Current Status of EVAR for Infrarenal AAA 31 st Annual Florida Vascular Society PENN Surgery No Disclosures Stent Grafts Design Related Differences What really matters? Modular Unibody Supported Unsupported
More informationDurability of The Endurant Stent-Graft through 5 Years
Durability of The Endurant Stent-Graft through 5 Years Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh School
More informationYoung-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,
Young-Guk Ko, M.D., Dangas G, J Am Coll Cardiol Intv 2012;5:1071 All-cause Mortality Dangas Severance G, J Am Coll Cardiovascular Cardiol Intv Hospital, 2012;5:1071 Yonsei University Health System Aneurysm-related
More informationOptimizing Accuracy of Aortic Stent Grafts in Short Necks
Optimizing Accuracy of Aortic Stent Grafts in Short Necks Venkatesh Ramaiah, MD, FACS Medical Director Arizona Heart Hospital Director Peripheral Vascular and Endovascular Research Arizona Heart Institute
More informationFrom the Western Vascular Society
From the Western Vascular Society The role of aortic neck dilation and elongation in the etiology of stent graft migration after endovascular abdominal aortic aneurysm repair with a passive fixation device
More informationDegeneration of the Neck Post Implementation - a New Era of AAA Stent
Degeneration of the Neck Post Implementation - a New Era of AAA Stent New Mexico Heart Institute Albuquerque, New Mexico USA - Gore Current FDA-Approved EVAR Devices Sealing Mechanism Endologix Lombard
More informationEVAR replaced standard repair in most cases. Why?
EVAR replaced standard repair in most cases. Why? Initial major steps in endograft evolution Papazoglou O. Konstantinos M.D. The story of a major breakthrough in vascular surgery 1991 Parodi introduces
More informationA New EVAR Device for Infrarenal AAAs
A New EVAR Device for Infrarenal AAAs Peter Nelson, MD, MS Assistant Professor of Surgery MM0203 Rev. 01 Current U.S. EVAR Devices Anatomical Fixation Proximal Fixation Powerlink - Endologix Excluder WL
More informationConsiderations for a Durable Repair
Considerations for a Durable Repair Eric Verhoeven, MD, PhD, A. Katsargyris, MD Department of Vascular and Endovascular Surgery, Paracelsus Medical University, Nuremberg, Germany Disclosures William Cook
More informationTriVascular Ovation Prime Abdominal Stent Graft System
TriVascular Ovation Prime Abdominal Stent Graft System Science of the Seal O-Ring Sealing Technology O-Ring Sealing in Proven Engineering Solutions O-rings are designed to seal by blocking the flow of
More informationHostile Proximal Neck: A New Conformable EVAR Device
Hostile Proximal Neck: A New Conformable EVAR Device Young-Guk Ko, M.D., Seoul, Korea Currently Available Devices for EVAR in Korea, 2018 Zenith Flex, Cook Endurant IIs, Medtronic INCRAFT, Cordis AFX2,
More informationAcute dissections of the descending thoracic aorta (Debakey
Endovascular Treatment of Acute Descending Thoracic Aortic Dissections Nimesh D. Desai, MD, PhD, and Joseph E. Bavaria, MD Acute dissections of the descending thoracic aorta (Debakey type III or Stanford
More informationAnatomical challenges in EVAR
Anatomical challenges in EVAR M.H. EL DESSOKI, MD,FRCS PROFESSOR OF VASCULAR SURGERY CAIRO UNIVERSITY Disclosure Speaker name:... I have the following potential conflicts of interest to report: Consulting
More informationMorphological Study of Abdominal Aortic Aneurysm: Optimal Stent-graft Size for Japanese Patients
Original Article Morphological Study of Abdominal Aortic Aneurysm: Optimal Stent-graft Size for Japanese Patients Hirofumi Midorikawa, MD, Tomohiro Ogawa, MD, Kouichi Satou, MD, and Shunichi Hoshino, MD
More informationCook Medical. Zenith Flex AAA Endovascular Graft with Z-Trak Introduction System Physician Training
Cook Medical Zenith Flex AAA Endovascular Graft with Z-Trak Introduction System Physician Training Bifurcated system Proximal suprarenal stent Modular (aortic main body and two iliac legs) Full-thickness,
More informationImproving Endograft Durability with EndoAnchors
Improving Endograft Durability with EndoAnchors William D. Jordan, Jr., M.D. John E. Skandalakis Chair in Surgery Professor and Chief Division of Vascular Surgery and Endovascular Therapy Emory University
More informationNellix Endovascular System: Clinical Outcomes and Device Overview
Nellix Endovascular System: Clinical Outcomes and Device Overview Jeffrey P. Carpenter, MD Professor and Chief, Department of Surgery CAUTION: Investigational device. This product is under clinical investigation
More informationChallenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment
Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment Robert Y. Rhee, MD Chief, Vascular and Endovascular Surgery Director, Aortic Center Maimonides Medical Center Brooklyn,
More informationThe Short Proximal AAA Neck
The Short Proximal AAA Neck A comparison of EVAR outcomes among groups of patients with different proximal neck lengths. BY ALEXANDRA A. MACLEAN, MD, AND BARRY T. KATZEN, MD, FOR THE BCVI ENDOVASCULAR
More informationAnatomy-Driven Endograft Selection for Abdominal Aortic Aneurysm Repair S. Jay Mathews, MD, MS, FACC
Anatomy-Driven Endograft Selection for Abdominal Aortic Aneurysm Repair S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton, FL, USA Disclosures
More informationThe clinical update for the Zenith AAA Endovascular Graft has included results from the Zenith AAA Endovascular Graft multi-center clinical study,
The clinical update for the Zenith AAA Endovascular Graft has included results from the Zenith AAA Endovascular Graft multi-center clinical study, the 36 mm diameter Zenith Flex AAA Endovascular Graft
More informationOvation. Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic
Ovation Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement
More informationTechnique and Tips for Complicated AAA Cases with Stent Graft
Technique and Tips for Complicated AAA Cases with Stent Graft Seung-Woon Rha, MD, PhD FACC, FAHA, FESC, FSCAI, FAPSIC Cardiovascular Center, Korea University Guro Hospital Mar 15, 2018 LINC AP 2018 Endoleak;
More informationGORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability. Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands
GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts
More informationMODERN METHODS FOR TREATING ABDOMINAL ANEURYSMS AND THORACIC AORTIC DISEASE
MODERN METHODS FOR TREATING ABDOMINAL ANEURYSMS AND THORACIC AORTIC DISEASE AAA FACTS 200,000 New Cases Each Year Ruptured AAA = 15,000 Deaths per Year in U.S. 13th Leading Cause of Death 80% Chance of
More informationRobert F. Cuff, MD FACS SHMG Vascular Surgery
Robert F. Cuff, MD FACS SHMG Vascular Surgery Objectives To become familiar with the commercially available fenestrated EVAR graft Discuss techniques to increase success Review available data to determine
More informationMy personal experience with INCRAFT in standard and challenging cases
My personal experience with INCRAFT in standard and challenging cases G Pratesi, MD Vascular Surgery University of Rome Tor Vergata giovanni.pratesi@uniroma2.it Disclosure Speaker name: Giovanni Pratesi,
More informationChallenging anatomies demand versatility.
Challenging anatomies demand versatility. The Distinct Advantages of Separating Seal and Fixation ANATOMICAL FIXATION Unlike proximal fixation designs, the AFX bifurcated unibody endograft allows for natural
More informationManagement of Endoleaks
Management of Endoleaks Sarah Ikponmwosa, MD Brooklyn VA 6/20/08 Questions Advantages of endovascular repair Definition of an endoleak Types of endoleaks Management of type lll endoleak Diagnosis of type
More informationLow profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster
Low profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster Disclosure Speaker name:...michel Bosiers... I have the following potential conflicts of interest to report: Consulting Employment
More information3. Endoluminal Treatment of Infrarenal Abdominal Aortic Aneurysm
3. Endoluminal Treatment of Infrarenal Abdominal Aortic Aneurysm Hence J. M. Verhagen, Geoffrey H. White, Tom Daly and Theodossios Perdikides A 78-year-old male was referred for investigation and management
More informationIndications for use. Contraindications within the United States
Indications for use Indications within the United States The GORE TAG Thoracic Endoprosthesis is intended for endovascular repair of all lesions of the descending thoracic aorta, including: Isolated lesions
More informationRight Choice for Right Angles
Right Choice for Right Angles The Anatomy of Technology Aorfix gives you technology that conforms to patient anatomy, optimising both procedure and post-operative performance. Fishmouth for optimum neck
More informationFROM THE EVERYDAY TO THE EXTRAORDINARY
FROM THE EVERYDAY TO THE EXTRAORDINARY Created with the collaboration of more than 250 physicians around the world, ENDURANT empowers you to create stronger outcomes for more patients, including those
More informationI SECTION I. Thoracic aortic aneurysms
I SECTION I Thoracic aortic aneurysms 9 10 CASE 1 Endovascular repair of descending thoracic aortic aneurysms using the Gore TAG stent graft Introduction A descending thoracic aneurysm (DTA) is defined
More informationThe First 150 Endovascular AAA Repairs at a Single Institution: How Steep Is the Learning Curve?
J ENDOVASC THER 69 CLINICAL INVESTIGATION The First 50 Endovascular AAA Repairs at a Single Institution: How Steep Is the Learning Curve? W. Anthony Lee, MD; Yehuda G. Wolf, MD; Bradley B. Hill, MD; Paul
More informationPercutaneous Approaches to Aortic Disease in 2018
Percutaneous Approaches to Aortic Disease in 2018 Wendy Tsang, MD, SM Assistant Professor, University of Toronto Toronto General Hospital, University Health Network Case 78 year old F Lower CP and upper
More informationFEVAR FIFTEEN YEARS OF EFFICIENCY E.DUCASSE MD PHD FEBVS CHU DE BORDEAUX
FEVAR FIFTEEN YEARS OF EFFICIENCY E.DUCASSE MD PHD FEBVS CHU DE BORDEAUX 2018 A BIT OF HISTORY First use of F-EVAR : 1990s Park et al. J Vasc Interv Radiol. 1996;7:819-823. Faruqi et al. J Endovasc Surg.
More informationAortic neck angulation predicts adverse outcome with endovascular abdominal aortic aneurysm repair
Aortic neck angulation predicts adverse outcome with endovascular abdominal aortic aneurysm repair W. Charles Sternbergh III, MD, a Glen Carter, RT (R)(CV), a John W. York, MD, a Moises Yoselevitz, MD,
More informationPeriprosthetic leak and rupture after endovascular repair of abdominal aortic aneurysm: The significance of device design for long-term results
CASE REPORTS Periprosthetic leak and rupture after endovascular repair of abdominal aortic aneurysm: The significance of device design for long-term results Kirsten Krohg-Sørensen, MD, PhD, Magne Brekke,
More information12-year Experience with the Endologix Powerlink R Device in Endovascular Repair of Abdominal Aortic Aneurysms
11 12-year Experience with the Endologix Powerlink R Device in Endovascular Repair of Abdominal Aortic Aneurysms Ziheng Wu 1, Lefeng Qu 2, Dieter Raithel 3 and Konstantinos Xiromeritis³ 1 Department of
More informationThe Ventana Off-the-Shelf Graft for Pararenal AAA. Andrew Holden Associate Professor of Radiology Auckland Hospital
The Ventana Off-the-Shelf Graft for Pararenal AAA Andrew Holden Associate Professor of Radiology Auckland Hospital Disclosures Andrew Holden, MBChB, FRANZCR Investigator in Nellix and Ventana Trials Clinical
More informationTechnology. The introduction of endovascular aortic repair. cover story
Infrarenal EVAR Technology Review Steady evolution in device design and delivery has expanded endovascular repair to more patients, but further advancements are integral to this technology s future. By
More information2015 Clinical Update Endovascular Systems for AAA Repair
Endovascular Systems for AAA Repair 2 Musick Irvine, CA 92618 Tel 949.595.7200 Fax 949.612.1893 www.endologix.com TABLE OF CONTENTS Section Page ABSTRACT... 3 READER S GUIDE... 4 SECTION 1: US PIVOTAL
More informationTreatment of Thoracoabdominal Aneurysms Is there a need for custom-made devices?
: FETURED TECHNOLOGY: JOTEC E-XTR DESIGN ENGINEERING Treatment of Thoracoabdominal neurysms Is there a need for custom-made devices? INTERVIEW ND CSE PRESENTTIONS WITH DNIEL RNZN, MD, ND NDREJ SCHMIDT,
More informationChallenges in the treatment of infrarenal aneurysm & considerations for a durable repair
Challenges in the treatment of infrarenal aneurysm & considerations for a durable repair Nilo J Mosquera, MD. Head of Department Angiology and Vascular Surgery. CHUO Hospital. Ourense. Spain Disclosure
More informationObesity, Scaring, Access in EVAR. Kiskinis D, Melas N, Ktenidis K. 1 st Department of Surgery Aristotle University of Thessaloniki, Greece
Obesity, Scaring, Access in EVAR Kiskinis D, Melas N, Ktenidis K. 1 st Department of Surgery Aristotle University of Thessaloniki, Greece Obesity Decreased radiolucency (visibility) Max weight load < 160
More informationsymptomatic aneurysms or aneurysms that grow >1cm/yr
1. Elective repair for aneurysm >5.5 cm, symptomatic aneurysms or aneurysms that grow >1cm/yr 2. Ruptured AAA Aneurysm Detection and Management Study (ADAM) and UK Small Aneurysm Trial early open surgery
More informationThe evolution. AORFIX AAA Stent Graft now with the new AORFLEX Delivery System
The evolution of AORFIX AORFIX AAA Stent Graft now with the new AORFLEX Delivery System The confident choice for the right angles AORFIX the only AAA stent graft approved for all angulations from 0 90,
More informationEndovascular Repair or Surveillance of Patients with Small AAA
Eur J Vasc Endovasc Surg 29, 496 503 (2005) doi:10.1016/j.ejvs.2005.03.003, available online at http://www.sciencedirect.com on Endovascular Repair or Surveillance of Patients with Small AAA C.K. Zarins,
More informationVentana Fenestrated Stent-Graft System for Endovascular Repair of Juxtarenal Aortic Aneurysms
J ENDOVASC THER 173 TECHNICAL NOTE Ventana Fenestrated Stent-Graft System for Endovascular Repair of Juxtarenal Aortic Aneurysms Renato Mertens, MD; Michel Bergoeing, MD; Leopoldo Mariné, MD; Francisco
More informationENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients
ENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients The Ovation System is approved to treat infrarenal abdominal aortic aneurysms and is not
More informationRadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.
Interventional Radiology Coding Case Studies Prepared by Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC, AAPC Fellow President & Senior Consultant INDICATION: Abdominal aortic aneurysm. INTERVENTIONAL RADIOLOGIST:
More informationAbdominal Aortic Aneurysms. A Surgeons Perspective Dr. Derek D. Muehrcke
Abdominal Aortic Aneurysms A Surgeons Perspective Dr. Derek D. Muehrcke Aneurysm Definition The abnormal enlargement or bulging of an artery caused by an injury or weakness in the blood vessel wall A localized
More informationMid-term results from ANCHOR: How does this data influence the treatment algorithm for hostile EVAR anatomies
Mid-term results from ANCHOR: How does this data influence the treatment algorithm for hostile EVAR anatomies Jean-Paul P.M. de Vries Head Department of Surgery, University Medical Centre Groningen The
More informationAbdominal Aortic Aneurysm 가천대길병원 이상준
Abdominal Aortic Aneurysm 가천대길병원 이상준 1 Definition Diameter of the aorta 1.5 times greater than normal. Most are infrarenal, and a significant number extend down into one or both iliac arteries Abdominal
More informationCase Report Early and Late Endograft Limb Proximal Migration with Resulting Type 1b Endoleak following an EVAR for Ruptured AAA
Hindawi Case Reports in Vascular Medicine Volume 2017, Article ID 4931282, 5 pages https://doi.org/10.1155/2017/4931282 Case Report Early and Late Endograft Limb Proximal Migration with Resulting Type
More informationTaming The Aorta. David Minion, MD Program Director, Vascular Surgery University of Kentucky Medical Center Lexington, Kentucky, USA
Taming The Aorta David Minion, MD Program Director, Vascular Surgery University of Kentucky Medical Center Lexington, Kentucky, USA Faculty Disclosure Consulting: Endologix, Cook 1 Objectives Review the
More informationAncillary Components with Z-Trak Introduction System
Ancillary Components with Z-Trak Introduction System Zenith Flex AAA Endovascular Graft Ancillary Components Converter Converters can be used to convert a bifurcated graft into an aortouniiliac graft if
More informationCase Report Late Type 3b Endoleak with an Endurant Endograft
Case Reports in Radiology Volume 2015, Article ID 783468, 4 pages http://dx.doi.org/10.1155/2015/783468 Case Report Late Type 3b Endoleak with an Endurant Endograft Mehmet Barburoglu, 1 Bulent Acunas,
More informationType-II Endoleaks Following Endovascular AAA Repair: Preoperative Predictors and Long-term Effects
503 VASCULAR FELLOWS FORUM 2001, FIRST PLACE Type-II Endoleaks Following Endovascular AAA Repair: Preoperative Predictors and Long-term Effects Frank R. Arko, MD; Geoffrey D. Rubin, MD; Bonnie L. Johnson,
More informationHostile Neck During EVAR, The Role Of Endoanchores
Hostile Neck During EVAR, The Role Of Endoanchores Samer Koussayer, MD, FACS, RVT Prof, Al Faisal University Section Head and consultant Vascular & Endovascular Surgery Division King Faisal Specialist
More informationAortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice
Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice Eric Verhoeven, MD, PhD, A. Katsargyris, MD Department of Vascular and Endovascular Surgery, Paracelsus Medical University,
More informationAnnual Clinical Update
Zenith TX2 TAA Endovascular Graft (P716) Annual Clinical Update (216) Page i Annual Clinical Update Abstract Cook is pleased to provide you with this clinical update on the Zenith TX2 TAA Endovascular
More informationINCRAFT system: Update from the Pivotal INSPIRATION Study
INCRAFT system: Update from the Pivotal INSPIRATION Study Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh
More informationUse of Aptus Heli-FX EndoAnchor implants with standard endografts to strengthen seal in hostile anatomies:
Use of Aptus Heli-FX EndoAnchor implants with standard endografts to strengthen seal in hostile anatomies: technical tips, case experience and clinical results CACVS Medtronic Symposium Paris, France January
More informationEndoleak Visualized With Carbon Dioxide Angiography During Endovascular Aneurysm Repair Using the Endurant Stent-Graft
172 J ENDOVASC THER 2014;21:172 176 CASE REPORT Endoleak Visualized With Carbon Dioxide Angiography During Endovascular Aneurysm Repair Using the Endurant Stent-Graft Robert P. Garvin, MD; Evan J. Ryer,
More informationUNCORRECTED PROOF ARTICLE IN PRESS. Endovascular Repair or Surveillance of Patients with Small AAA
Eur J Vasc Endovasc Surg xx, 1 8 (xxxx) doi:10.1016/j.ejvs.2005.03.003, available online at http://www.sciencedirect.com on 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
More informationLength Measurements of the Aorta After Endovascular Abdominal Aortic Aneurysm Repair
Eur J Vasc Endovasc Surg 18, 481 486 (1999) Article No. ejvs.1999.0882 Length Measurements of the Aorta After Endovascular Abdominal Aortic Aneurysm Repair J. J. Wever, J. D. Blankensteijn, I. A. M. J.
More informationAbdominal aortic aneurysm repair with the Zenith stent graft: Short to midterm results
Abdominal aortic aneurysm repair with the Zenith stent graft: Short to midterm results Cherrie Z. Abraham, MD, Timothy A. M. Chuter, MD, Linda M. Reilly, MD, Stephen P. Okuhn, MD, Lisa K. Pethan, BSN,
More informationManagement of Endoleaks. Michael Meuse, M.D Vascular and Interventional Radiology 12/14/09
Management of Endoleaks Michael Meuse, M.D Vascular and Interventional Radiology 12/14/09 Endoleak Failure to totally exclude the abdominal aortic aneurysm (AAA) from continued perfusion and pressurization
More informationCurrent Use of Endovascular Grafts for the Treatment of Abdominal Aortic Aneurysms
IAGS Proceedings N O RT H & S O U T H: N O N-C A R D I A C R E VA S C U L A R I Z AT I O N Current Use of Endovascular Grafts for the Treatment of Abdominal Aortic Aneurysms Peter L. Faries, MD, James
More informationManagement of Endoleaks
Management of Endoleaks Murray Shames, MD Professor and Chief, Director Tampa General Hospital Aortic Program Vice Chair of Research, Dept. of Surgery Conflict of Interests: Speaker: Gore, Medtronic, Cook
More informationHow to Categorize the Infrarenal Neck Properly? I Van Herzeele Dept. Thoracic and Vascular Surgery, Ghent University, Belgium
How to Categorize the Infrarenal Neck Properly? I Van Herzeele Dept. Thoracic and Vascular Surgery, Ghent University, Belgium Disclosure Speaker name: Isabelle Van Herzeele I have the following potential
More informationEndovascular Aneurysm Sealing System for Treating Abdominal Aortic Aneurysms: Early Outcomes from a Single Center
Endovascular Aneurysm Sealing System for Treating Abdominal Aortic Aneurysms: Early Outcomes from a Single Center Thiti Chanmayka MD*, Anucha Ahooja MD**, Chalach Mitprachapranee MD*, Chawalit Wongbhuddha
More informationAAA: DEBATE THERE ARE NO LIMITS USING EVAR FOR AAA. 2 nd -3 rd June 2016.
AAA: DEBATE THERE ARE NO LIMITS USING EVAR FOR AAA JORGE FERNÁNDEZ NOYA ANGIOLOGY AND VASCULAR SURGERY DEPARTMENT UNIVERSITARY CLINICAL HOSPITAL SANTIAGO DE COMPOSTELA 2 nd -3 rd June 2016. 1888 ENDOANEURYSMORRHAPHY
More informationType 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany
Type 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany Disclosures Speaker name: Dittmar Böckler I have the following potential conflicts
More informationGORE EXCLUDER AAA Endoprosthesis ANNUAL CLINICAL UPDATE OCTOBER Section I Clinical experience. Section II Worldwide commercial experience
GORE EXCLUDER AAA Endoprosthesis ANNUAL CLINICAL UPDATE OCTOBER 2018 Abstract This annual clinical update provides a review of the ongoing experience with the GORE EXCLUDER AAA Endoprosthesis used in the
More informationUse of covered stents and endograft as a rescue treatment in a patient with a complex form of recurrent aortic coarctation
TECHNICAL NOTE Use of covered stents and endograft as a rescue treatment in a patient with a complex form of recurrent aortic coarctation Juan C. Parodi, MD, Luis Mariano Ferreira, MD, Horacio Faella,
More information6. Endovascular aneurysm repair
Introduction The standard treatment for aortic aneurysm, open repair, involves a large abdominal incision and cross-clamping of the aorta. In recent years, a minimally invasive technique, endovascular
More informationDisclosures. EVAR follow-up: actual recommendation. EVAR follow-up: critical issues
Disclosures is it time to discuss individualized follow-up schemes based on preoperative anatomy and high quality completion angiography? Consultant / Speaker / Proctor Cook Cordis Medtronic Invatec W.L.
More information